LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb studyYanhang Gao, Junqi Niu, Xieer Liang et al.|Journal of Hepatology|2025Cited by 2
Sex Differences Across Corticosteroid Response and Outcomes in IgA NephropathyDana Kim, Zhihong Liu, Vivekanand Jha et al.|Kidney International Reports|2025Cited by 1